The combination was simultaneously approved in Australia and Canada and was the first such action under a new international collaboration.
A new study looked at median overall survival for patients with prior antibiotic therapy compared with patients with no prior antibiotic therapy.
Age disparities in oncology trials are continuing, despite opposition to this issue.
Two doctors discuss their research on how use of alternative over traditional medicine affects survival rates in patients with cancer and how oncologists can approach the age of medical misinformation.
Study researchers polled 607 women who'd been previously diagnosed with breast cancer to see how recovery time, surgical complications, and cost factored into their decision to receive surgery during treatment.
A new study shows patients with advanced non–small-cell lung cancer have preferences on which chemotherapy side effects they'd prefer to avoid which highlights the importance of incorporating patient preferences into treatment.
Underinsured patients use websites like GoFundMe to pay medical bills after being diagnosed with cancer, but many fundraising campaigns are unsuccessful.
The agency is now recommending prescribing certain medications to postmenopausal women at an increased risk for breast cancer in order to help prevent them from developing the disease.
A new combo may benefit patients with HER-2 positive metastatic breast cancer, according to a new study.
A pooled analysis included extended-survival data from COMBI-d and COMBI-v trials, both of which included treatment-naïve patients with unresectable or metastatic melanoma who were randomized to receive either dabrafenib plus trametinib or BRAF inhibitor monotherapy.